Literature DB >> 26290245

Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.

Akihiko Ozawa1, Gloria Brunori1, Daniela Mercatelli2, Jinhua Wu1, Andrea Cippitelli1, Bende Zou3, Xinmin Simon Xie3, Melissa Williams1, Nurulain T Zaveri4, Sarah Low5, Grégory Scherrer5, Brigitte L Kieffer6, Lawrence Toll7.   

Abstract

The nociceptin/orphanin FQ (NOP) receptor, the fourth member of the opioid receptor family, is involved in many processes common to the opioid receptors including pain and drug abuse. To better characterize receptor location and trafficking, knock-in mice were created by inserting the gene encoding enhanced green fluorescent protein (eGFP) into the NOP receptor gene (Oprl1) and producing mice expressing a functional NOP-eGFP C-terminal fusion in place of the native NOP receptor. The NOP-eGFP receptor was present in brain of homozygous knock-in animals in concentrations somewhat higher than in wild-type mice and was functional when tested for stimulation of [(35)S]GTPγS binding in vitro and in patch-clamp electrophysiology in dorsal root ganglia (DRG) neurons and hippocampal slices. Inhibition of morphine analgesia was equivalent when tested in knock-in and wild-type mice. Imaging revealed detailed neuroanatomy in brain, spinal cord, and DRG and was generally consistent with in vitro autoradiographic imaging of receptor location. Multicolor immunohistochemistry identified cells coexpressing various spinal cord and DRG cellular markers, as well as coexpression with μ-opioid receptors in DRG and brain regions. Both in tissue slices and primary cultures, the NOP-eGFP receptors appear throughout the cell body and in processes. These knock-in mice have NOP receptors that function both in vitro and in vivo and appear to be an exceptional tool to study receptor neuroanatomy and correlate with NOP receptor function. SIGNIFICANCE STATEMENT: The NOP receptor, the fourth member of the opioid receptor family, is involved in pain, drug abuse, and a number of other CNS processes. The regional and cellular distribution has been difficult to determine due to lack of validated antibodies for immunohistochemical analysis. To provide a new tool for the investigation of receptor localization, we have produced knock-in mice with a fluorescent-tagged NOP receptor in place of the native NOP receptor. These knock-in mice have NOP receptors that function both in vitro and in vivo and have provided a detailed characterization of NOP receptors in brain, spinal cord, and DRG neurons. They appear to be an exceptional tool to study receptor neuroanatomy and correlate with NOP receptor function.
Copyright © 2015 the authors 0270-6474/15/3511683-12$15.00/0.

Entities:  

Keywords:  GPCR; N/OFQ; NOP receptor; eGFP; histochemistry; knock-in

Mesh:

Substances:

Year:  2015        PMID: 26290245      PMCID: PMC4540802          DOI: 10.1523/JNEUROSCI.5122-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene.

Authors:  I Kitchen; S J Slowe; H W Matthes; B Kieffer
Journal:  Brain Res       Date:  1997-12-05       Impact factor: 3.252

2.  Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis.

Authors:  N P Murphy; N T Maidment
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

3.  Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo.

Authors:  Grégory Scherrer; Petra Tryoen-Tóth; Dominique Filliol; Audrey Matifas; Delphine Laustriat; Yu Q Cao; Allan I Basbaum; Andrée Dierich; Jean-Luc Vonesh; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

4.  Orphanin FQ/nociceptin blocks acquisition of morphine place preference.

Authors:  N P Murphy; Y Lee; N T Maidment
Journal:  Brain Res       Date:  1999-06-19       Impact factor: 3.252

5.  Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; H Akil; S J Watson
Journal:  J Comp Neurol       Date:  1999-10-04       Impact factor: 3.215

6.  Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems.

Authors:  K Ikeda; M Watanabe; T Ichikawa; T Kobayashi; R Yano; T Kumanishi
Journal:  J Comp Neurol       Date:  1998-09-14       Impact factor: 3.215

7.  Distribution of ORL-1 receptor binding and receptor-activated G-proteins in rat forebrain and their experimental localization in anterior cingulate cortex.

Authors:  Laura J Sim-Selley; Leslie J Vogt; Steven R Childers; Brent A Vogt
Journal:  Neuropharmacology       Date:  2003-08       Impact factor: 5.250

Review 8.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

9.  Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms.

Authors:  T P Yu; C W Xie
Journal:  J Neurophysiol       Date:  1998-09       Impact factor: 2.714

10.  Antinociceptive and morphine modulatory actions of spinal orphanin FQ.

Authors:  K H Jhamandas; M Sutak; G Henderson
Journal:  Can J Physiol Pharmacol       Date:  1998-03       Impact factor: 2.273

View more
  28 in total

1.  Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Authors:  Louise M Collins; Giorgia Dal Bo; Mariangela Calcagno; Jimena Monzón-Sandoval; Aideen M Sullivan; Humberto Gutierrez; Michele Morari; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

2.  NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.

Authors:  Gloria Brunori; Michelle Weger; Jennifer Schoch; Katarzyna Targowska-Duda; Megan Barnes; Anna Maria Borruto; Linda M Rorick-Kehn; Nurulain T Zaveri; John E Pintar; Roberto Ciccocioppo; Lawrence Toll; Andrea Cippitelli
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

3.  NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.

Authors:  Katarzyna M Targowska-Duda; Akihiko Ozawa; Zachariah Bertels; Andrea Cippitelli; Jason L Marcus; Hanna K Mielke-Maday; Gilles Zribi; Amanda N Rainey; Brigitte L Kieffer; Amynah A Pradhan; Lawrence Toll
Journal:  Neuropharmacology       Date:  2020-03-06       Impact factor: 5.250

4.  NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.

Authors:  Anna Maria Borruto; Yannick Fotio; Serena Stopponi; Gloria Brunori; Michele Petrella; Francesca Felicia Caputi; Patrizia Romualdi; Sanzio Candeletti; Rajesh Narendran; Linda M Rorick-Kehn; Massimo Ubaldi; Friedbert Weiss; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

5.  A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward.

Authors:  Kyle E Parker; Christian E Pedersen; Adrian M Gomez; Skylar M Spangler; Marie C Walicki; Shelley Y Feng; Sarah L Stewart; James M Otis; Ream Al-Hasani; Jordan G McCall; Kristina Sakers; Dionnet L Bhatti; Bryan A Copits; Robert W Gereau; Thomas Jhou; Thomas J Kash; Joseph D Dougherty; Garret D Stuber; Michael R Bruchas
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

6.  In vivo mapping of a GPCR interactome using knockin mice.

Authors:  Jade Degrandmaison; Khaled Abdallah; Véronique Blais; Samuel Génier; Marie-Pier Lalumière; Francis Bergeron; Catherine M Cahill; Jim Boulter; Christine L Lavoie; Jean-Luc Parent; Louis Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-26       Impact factor: 11.205

Review 7.  Targeting multiple opioid receptors - improved analgesics with reduced side effects?

Authors:  Thomas Günther; Pooja Dasgupta; Anika Mann; Elke Miess; Andrea Kliewer; Sebastian Fritzwanker; Ralph Steinborn; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2017-05-26       Impact factor: 8.739

Review 8.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

9.  Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.

Authors:  Akihiko Ozawa; Gloria Brunori; Andrea Cippitelli; Nicholas Toll; Jennifer Schoch; Brigitte L Kieffer; Lawrence Toll
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

10.  Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic.

Authors:  G Calo; D G Lambert
Journal:  Br J Anaesth       Date:  2018-08-22       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.